Back

Routine oral glucose tolerance test to improve risk stratification in acute coronary syndrome patients

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Simona Chiusolo

Pisa University Hospital, Pisa (Italy)

8 More presentations in this session

Presentation thumbnail
Discussant - Biomarkers and assessing outcomes in coronary artery disease
Presentation thumbnail
Association between cortisol, glucose and hospital mortality in acute coronary syndromes: a causal inference analysis.
Doctor S. Swieszkowski (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Comparative predictive value of troponin I and troponin T for in-hospital ischemic and bleeding events in acute coronary syndrome
Doctor J. Costabel (Buenos Aires, AR)
Abstract
Presentation thumbnail
Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies
Doctor H. Wada (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Undiagnosed impaired glucose tolerance/diabetes mellitus and relationship with aortic stiffness in patients with acute coronary syndromes
thumbnail
Congress Presentation
Diabetes and prediabetes prevalence and guideline directed antidiabetic therapy in acute coronary syndrome and complex coronary interventions
thumbnail
Congress Presentation
Routine HbA1c screening identifies de novo (pre)diabetes mellitus in 37% of ACS patients which comes with an even higher ischemic risk compared to known diabetes mellitus

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources